• SmartestCrowd
    • No organizations
    • No projects
0
0
Is there a difference in the risk of hospital admission between BA.1 and BA.2 cases treated with Sotrovimab? - News-Medical.Net
10/25/22 at 5:32am
Organization
News-Medical.Net
41 words
0
Comments
Researchers compared the risk associated with hospitalization of sotrovimab-treated individuals infected with SARS-CoV-2 Omicron variants.
9 similar articles
New research suggests booster dose of Novovax NVX-CoV2373 vaccine is effective against SARS-CoV-2 Omicron subvariants - News-Medical.Net
Omicron BA.4/BA.5 bivalent mRNA vaccine booster elicits similar neutralizing antibody responses to monovalent vaccine - News-Medical.Net
Vaccination- and/or natural infection-induced immune responses against SARS-CoV-2 Omicron subvariants - News-Medical.Net
Vaccination- and/or natural infection-induced immune responses against SARS-CoV-2 Omicron subvariants - News-Medical.Net
Vaccination- and/or natural infection-induced immune responses against SARS-CoV-2 Omicron subvariants - News-Medical.Net
Vaccination- and/or natural infection-induced immune responses against SARS-CoV-2 Omicron subvariants - News-Medical.Net
Vaccination- and/or natural infection-induced immune responses against SARS-CoV-2 Omicron subvariants - News-Medical.Net
Vaccination- and/or natural infection-induced immune responses against SARS-CoV-2 Omicron subvariants - News-Medical.Net
The effectiveness of BNT162b2 COVID-19 vaccine against infection with SARS-CoV-2 Omicron subvariants BA.4/5 - News-Medical.Net
You are the first to view
https://www.news-medical.net/news/20221025/Is-there-a-difference-in-the-risk-of-hospital-admission-between-BA1-and-BA2-cases-treated-with-Sotrovimab.aspx
Create an account or login to join the discussion